A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Valeo Pharma Inc. Stock Quotes

For access to Time and Sales, you must have attained an Agoracom ranking of at least Treasurer.